Lumenis Introduces LightSheer(R) INFINITY(TM) and LightSheer(R) DESIRE(TM) to the European Market at the Anti-Aging Medicine World Congress (AMWC)

The Gold Standard LightSheer(R) Laser Hair Removal Franchise Now Includes a Solution to Fit Every Practice and Patient Type; The Q-Switched Nd:YAG Module Adds New Capabilities to the M22(TM) Multi-Application Platform

Marketwired
Lumenis lance LightSheer(R) INFINITY(TM) et LightSheer(R) DESIRE(TM) sur le marché européen à l'occasion du congrès mondial de médecine anti-vieillissement (Anti-Aging Medicine World Congress - AMWC)
.

View photo

Le LightSheer DESIRE de Lumenis

YOKNEAM, ISRAEL--(Marketwired - Apr 3, 2014) - Lumenis Ltd. (NASDAQ: LMNS), the world's largest medical laser company for aesthetic, surgical and ophthalmic applications, announced today that the new LightSheer® INFINITY™ and LightSheer® DESIRE™ laser hair reduction products will be introduced in Europe at the 12th Anti-Aging Medicine World Congress (AMWC), taking place in Monte-Carlo on April 3-5, 2014. The new products will also be featured at the American Society for Laser Medicine and Surgery (ASLMS) Annual Conference, taking place in Phoenix, Arizona on April 2-6, 2014. Attendees at the meetings can visit the Lumenis booth, # B4 at AMWC and # 509 at ASLMS, for demonstrations of the new products.

Both LightSheer® INFINITY™ and LightSheer® DESIRE™ are up to 75 percent faster than other available devices and use Lumenis' proprietary HIT™ (High-Speed Integrated Technology) and ChillTip™ technologies for enhanced efficacy and patient comfort.

LightSheer® INFINITY™ is Lumenis' most advanced laser hair removal workstation. It features two gold-standard wavelengths, 805nm for all skin types, and 1060nm, the optimal solution for tanned and dark skin types.

LightSheer® DESIRE™ is both portable and upgradable, enabling users to add new capabilities as their practice grows. The advanced user interface allows easy treatment delegation and a quick learning curve.

Lumenis' existing laser hair reduction solutions, the LightSheer® DUET™ and LightSheer® ET, are recognized as industry gold standards. More than 50 peer reviewed articles confirm the superior efficacy, safety, comfort and high patient satisfaction achieved with LightSheer products.

In addition to the expansion of the LightSheer® franchise, Lumenis will also be featuring a new addition to the M22™ multi-application platform, the Q- Switched Nd:YAG module, at the Anti-Aging Medicine World Congress. The Q-Switched Nd:YAG module is designed for skin toning (by treatment of pigmented lesions), dark tattoo removal and can also be used for advanced combination treatments with other M22™ modalities. This cost-effective upgrade to the M22™ platform features five spot sizes for versatility in applications and a top-hat, homogenous beam profile for optimal patient safety.

"These new innovations are designed to reflect the diverse needs of both providers and patients," said Tzipi Ozer-Armon, CEO of Lumenis. "LightSheer®, the gold standard for laser hair reduction, and the M22™ multi-application platform, are cornerstones of the most comprehensive portfolio of laser and energy-based technologies in dermatology and aesthetics. Lumenis intends to leverage its strong presence in Europe to help providers integrate these new products into their practices and deliver outstanding results for patients."

12th Anti-Aging Medicine World Congress Activities and Presentations

Lumenis Champagne Reception Introducing LightSheer® DESIRE™, LightSheer® INFINITY™ and the Q-Switched Nd:YAG Module for M22™
Thursday, April 3, 2014, from 16:00 - 16:30 CET
Booth # B4

Lumenis Symposium: 360° of Rejuvenation with the M22™ Multi-application System
Friday, April 4, 2014, from 15:00 - 16:00 CET
Room Ravel

About Lumenis

Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. Our drive for innovation stems from an uncompromising commitment to improving the health and well-being of our patients; addressing new and growing needs of aging populations; and in offering medical professionals cutting-edge solutions that fit seamlessly into the health-economics environment of the 21st century. The world over, we bring Energy to Healthcare.

For more information visit: www.lumenis.com

Contact:
For further information:
Jeff Jacomowitz
Lazar Partners Ltd.
(212) 867-1762
View Comments (0)